ALT logo

Altimmune, Inc.

ALT
Healthcare|Biotechnology|US
$2.08
+0.11 (+5.58%)
DCF Value
$0.08
Tangible Book / Share
$2.56
Cash / Share
$1.76
Next Earnings Report
Nov 12, 2026
EPS est. -$0.14 · Revenue est. $1.8K
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Apr 24, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Sep 2027
Est. completion
P2Alcohol-associated Liver Disease
RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
NCT07009860n=121
Dec 2028
Est. completion
P3Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
NCT07795164n=1,800

Recent Press Releases

Altimmune Announces Data from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder Selected as Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2026
Nov 5, 2026 · GlobeNewsWire
Altimmune to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
Nov 5, 2026 · GlobeNewsWire
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
Oct 27, 2026 · GlobeNewsWire
Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting® 2026
Oct 19, 2026 · GlobeNewsWire
Altair Semiconductor Integrates Iridium NTN Direct into ALT1350 and ALT1550 Cellular IoT Chipsets
Oct 14, 2026 · PRNewsWire
Altimmune to Participate in Stifel Cardiometabolic Forum
Sep 23, 2026 · GlobeNewsWire
Alpha Liquid Terminal Relaunches as the ALT/X Compute Terminal, Pivoting to GPU Pricing, Power and AI Infrastructure Market Data
Sep 9, 2026 · GlobeNewsWire
Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
Sep 3, 2026 · GlobeNewsWire
Altimmune Announces Second Quarter 2026 Financial Results and Business Update
Aug 12, 2026 · GlobeNewsWire

SEC Filings (65)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 29, 20268-KMaterial eventDocumentIndex
Oct 27, 20268-KMaterial eventDocumentIndex
Sep 29, 20268-KMaterial eventDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Jul 28, 20268-KMaterial eventDocumentIndex
Jun 16, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 2026S-8Employee stock planDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
May 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 1, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 1, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 1, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 24, 20268-KMaterial eventDocumentIndex
Apr 24, 2026424B5Offering prospectusDocumentIndex
Apr 22, 2026S-3MEFShelf registrationDocumentIndex
Apr 22, 2026424B5Offering prospectusDocumentIndex
Apr 16, 20268-KMaterial eventDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 17, 2026ARSAnnual report to holdersDocumentIndex
Mar 17, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 6, 2026PRE 14AProxy / shareholder voteDocumentIndex
Mar 6, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 6, 2026S-8Employee stock planDocumentIndex
Feb 3, 20268-KMaterial eventDocumentIndex
Jan 30, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 28, 20268-KMaterial eventDocumentIndex
Jan 28, 2026424B5Offering prospectusDocumentIndex
Dec 19, 20258-KMaterial eventDocumentIndex
Dec 5, 2025EFFECTDocumentIndex
Dec 1, 20258-KMaterial eventDocumentIndex
Nov 13, 2025S-3/AShelf registrationDocumentIndex
Nov 6, 2025S-3Shelf registrationDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Nov 6, 2025424B5Offering prospectusDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex